Core Difference Between OAT and CPAP: Different Mechanisms of Action

Both target obstructive sleep apnea but through fundamentally different mechanisms:

  • CPAP (Continuous Positive Airway Pressure): Delivers pressurized air through a mask to pneumatically splint the upper airway open. Strongest evidence in severe OSA, significant hypoxemia, and complex central sleep apnea.
  • OAT (Oral Appliance Therapy): A custom oral appliance worn nightly that structurally advances the mandible 3–8 mm, enlarging the retroglossal and retropalatal spaces and reducing collapse risk anatomically. No electricity, no noise, portable.

Since 2015, the AASM × AADSM Joint Guideline explicitly lists OAT as a primary treatment option for adults with OSA who cannot tolerate CPAP or prefer alternative therapy. The 2024 update incorporates additional clinical evidence consolidating this status.

By Severity and Lifestyle: OAT or CPAP?

The decision framework below integrates AASM guideline recommendations with common clinical contexts (actual selection requires joint evaluation by a sleep physician and a dentist):

Clinical ContextMainstream Recommendation
Mild OSA (AHI 5–15), simple snoringOAT first-line
Moderate OSA (AHI 15–30), no severe comorbidityOAT or CPAP, patient-preference driven
Severe OSA (AHI ≥ 30), significant hypoxemiaCPAP first-line; OAT considered after CPAP failure
CPAP intolerance, adherence < 4 hrs/nightOAT primary option
Frequent travel / shift work / campingOAT — portability advantage
Coexisting central sleep apneaCPAP / BiPAP

In short: "OSA isn't severe + tried CPAP without success + need portability" → OAT is the mainstream answer. Severe disease still needs CPAP to control core physiological risk.

OSAWELL Differentiation: Taiwan's Only TFDA Class II Custom Medical-Grade OAT

Anti-snoring products on the market fall into three broad categories:

  • Non-medical OTC: No clinical evidence, no customization, no prescription. Long-term use carries risk of TMJ discomfort and bite alteration.
  • Semi-custom (thermoformed): Patient-molded at home; limited precision, no adjustable advancement.
  • Medical-grade custom: Fabricated from intraoral scans, prescribed by a dentist, with titratable advancement. OSAWELL is the only brand in this category in Taiwan holding TFDA Class II (Permit No. 008771) plus multiple Taiwan-US invention patents (GP-I820560), developed by a cross-disciplinary team at Taipei Medical University and recommended by the Taiwan Dental Sleep Medicine Academy (TDSMA).

The critical value of medical-grade custom OAT is not fit alone — it is that mandibular advancement can be incrementally adjusted by the dentist based on sleep-study AHI data, allowing treatment efficacy to be quantitatively verified and long-term adherence and adverse events to be tracked.